As of the 26th of February, Knight Therapeutics secures the Risk Adjusted Performance of 0.0433, mean deviation of 0.9723, and Downside Deviation of 1.21. Knight Therapeutics technical analysis lets you operate historical price patterns with an objective to determine a pattern that forecasts the direction of the firm's future prices.
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Knight, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to Knight
Knight
Knight Therapeutics' Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.
Please note, there is a significant difference between Knight Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Knight Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Knight Therapeutics' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Knight Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Knight Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Knight Therapeutics.
0.00
11/28/2025
No Change 0.00
0.0
In 3 months and 1 day
02/26/2026
0.00
If you would invest 0.00 in Knight Therapeutics on November 28, 2025 and sell it all today you would earn a total of 0.00 from holding Knight Therapeutics or generate 0.0% return on investment in Knight Therapeutics over 90 days. Knight Therapeutics is related to or competes with Cipher Pharmaceuticals, Vitalhub Corp, Aurora Cannabis, Canopy Growth, Kneat, TerrAscend Corp, and OrganiGram Holdings. Knight Therapeutics Inc. operates as a specialty pharmaceutical company in Canada and internationally More
Knight Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Knight Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Knight Therapeutics upside and downside potential and time the market with a certain degree of confidence.
Today, many novice investors tend to focus exclusively on investment returns with little concern for Knight Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Knight Therapeutics' standard deviation. In reality, there are many statistical measures that can use Knight Therapeutics historical prices to predict the future Knight Therapeutics' volatility.
As of now, Knight Stock is not too volatile. Knight Therapeutics has Sharpe Ratio of 0.0559, which conveys that the firm had a 0.0559 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Knight Therapeutics, which you can use to evaluate the volatility of the firm. Please verify Knight Therapeutics' Mean Deviation of 0.9723, downside deviation of 1.21, and Risk Adjusted Performance of 0.0433 to check out if the risk estimate we provide is consistent with the expected return of 0.0767%. Knight Therapeutics has a performance score of 4 on a scale of 0 to 100. The company secures a Beta (Market Risk) of 0.12, which conveys not very significant fluctuations relative to the market. As returns on the market increase, Knight Therapeutics' returns are expected to increase less than the market. However, during the bear market, the loss of holding Knight Therapeutics is expected to be smaller as well. Knight Therapeutics right now secures a risk of 1.37%. Please verify Knight Therapeutics standard deviation, value at risk, kurtosis, as well as the relationship between the sortino ratio and semi variance , to decide if Knight Therapeutics will be following its current price movements.
Auto-correlation
-0.15
Insignificant reverse predictability
Knight Therapeutics has insignificant reverse predictability. Overlapping area represents the amount of predictability between Knight Therapeutics time series from 28th of November 2025 to 12th of January 2026 and 12th of January 2026 to 26th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Knight Therapeutics price movement. The serial correlation of -0.15 indicates that less than 15.0% of current Knight Therapeutics price fluctuation can be explain by its past prices.
Correlation Coefficient
-0.15
Spearman Rank Test
-0.29
Residual Average
0.0
Price Variance
0.05
Knight Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Knight Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Knight Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...
Knight Therapeutics Technical Analysis
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Normalized Average True Range is used to analyze tradable apportunities for Knight Therapeutics across different markets.
About Knight Therapeutics Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Knight Therapeutics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Knight Therapeutics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Knight Therapeutics price pattern first instead of the macroeconomic environment surrounding Knight Therapeutics. By analyzing Knight Therapeutics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Knight Therapeutics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Knight Therapeutics specific price patterns or momentum indicators. Please read more on our technical analysis page.
Knight Therapeutics February 26, 2026 Technical Indicators
Most technical analysis of Knight help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Knight from various momentum indicators to cycle indicators. When you analyze Knight charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Knight Therapeutics February 26, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Knight stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
Knight Therapeutics financial ratios help investors to determine whether Knight Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Knight with respect to the benefits of owning Knight Therapeutics security.